Medical Marijuana Consultation

Medical Marijuana Consultation

New Patient Documentation
To prevent the spread of COVID-19 and reduce the potential risk exposure to our employees and patients please answer the following screening questions:
Have you returned from international travel or been on a cruise within the last 14 days?*

YesNo
Have you had close contact with or cared for someone diagnosed with COVID-19 within the last 14 days?*

YesNo
Have you experienced any cold or flu-like symptoms in the last 14 days (fever,cough, sore throat, difficulty breathing)?*

YesNo
If you answer “yes” to any of the above questions, please notify us immediately.

Thank you.
Name*

First NameLast Name
Date of Birth*

MonthDayYear
Date
Address*

Street Address

Street Address Line 2

CityState / Province

Postal / Zip Code
Sex:*

MaleFemale
Marital Status

MarriedSingle/DivorcedWidowed
Email*
example@example.com
Phone Number*
Please enter a valid phone number.
I consent to receive text/email messages for appointment reminders and/or information about my health care treatment:*

YesNo
Occupation:*
Do you have a medical marijuana card from any other state?*

YesNo
Are you currently on probation or Federal parole?*

YesNo
Are you a Florida resident?*

YesNo
Who referred you to our office?*
If self-referred, please write: "N/A"
Emergency Contact:*
Please include name, relation and his/her phone number
Primary Care Physician*
If not applicable, please write: "None"
Chief complaint (main reason for which you are seeking treatment):*
When did your symptoms start?*
Briefly, please describe your symptoms:*
Please check if you have history of any of the following conditions*

Chronic non-malignant painHIV/AIDSGlaucomaMultiple SclerosisEpilepsy/SeizuresCrohn's diseaseParkinson's diseaseCancerPTSDAmyotrophic Lateral Sclerosis (ALS)
Please check any history of:*

SchizophreniaAddiction/AlcoholismHeart DiseaseLiver DiseaseThyroid diseaseHigh Blood pressureLow Blood pressureKidney diseaseAnemiaClotsInfectionsDiabetesLung diseaseAnxiety/depressionNone
Please list any pertinent family history:
Please list any prior surgeries:*
If no surgeries, please write: "None"
Do you smoke?*

YesNo
Do you frequently drink alcohol?*

YesNo
Do you use illicit drugs?*

YesNo
(FEMALES ONLY) Are you currently pregnant or breast feeding?

YesNo
List current medications:*
If not taking any medications, please write: "None"
List any allergies to any medication(s)*
If no allergies, please write: "None"
AUTHORIZATION FOR RELEASE OF RECORDS
I hereby authorize Dr. Pedro T. Oliveros' office to obtain records from (doctor/hospital releasing information): * . Phone number: * . This authorization will expire in one year. I understand that this authorization is revocable upon written notice to the office where the original authorization is retained except to the extent that the action has already been taken on this authorization. Mental health, alcohol, drug, HIV and/or AIDS is confidentially protected by Federal and State law which prohibits disclosure without specific written authorization of the undersigned, or as otherwise permitted by such regulation. I understand that I may select the information from the list below to be released. Furthermore, I understand that any disclosure of information from my records carries with it the potential for an unauthorized re-disclosure of my health information.

I hereby authorize and request the above entity to release the following:
Diagnostic Tests Last 2 office notes*
Privacy Policy (Effective April 14, 2003)

Background

Medical offices are required by federal and state laws to maintain confidentiality of medical information generated for patients during their course of treatment. Legislation requires patients to be notified about privacy practices, our legal duties concerning these practices, and your rights concerning your health information. Our goal is to maintain confidentiality of your medical information. There are times, however, when identifiable health information must be disclosed to specific entities such as your insurance carrier. In these cases, we will only disclose information essential to comply with the request.

We reserve the right to change our policy related to health information collected and maintained, including information obtained before policy changes were determined to be necessary. As changes in our privacy practices are made, we will notify our patients of these changes.

In addition to our use of your health information for treatment, payment, or medical practice operations, you may give us written authorization to use your health information or to disclose it to anyone for any purpose. If you give us such authorization, you have the right to revoke it in writing at any time. Your revocation will not revoke any use or disclosures permitted by your authorization while it was in effect.

We may disclose your health information to:

^va family member, friend, or other person the extent necessary to assist us with your medical care or with payment for your medical care, but only if you agree that we may do so.
^vwhen we are required to do so by law through a subpoena.

^vto military authorities under certain circumstances

^vto correctional institutions or law enforcement officials having lawful custody of protected information of inmates or patients under certain circumstances.

We may disclose medical information of minor patients to appropriate authorities if we have reason to believe that they are possible victims of abuse, neglect, domestic violence, or other crimes. We may disclose your health information to the extent necessary to avert a serious threat to your health or safety or the health and safety of others.

Patient Rights
^vYou have the right to read over or obtain copies of your medical information.

^vYou have the right to receive a list of instances in which the practice has disclosed medical information for purposes other than treatment, payment, or medical practice operations. If requested more than once in a 6-month period, you will be charged our customary fee for responding to these requests.

^vYou have the right to request that we communicate with you regarding your medical information or treatment; any such requests must be in writing.

^vYou have the right to request that we amend the medical information that has been provided to you. Your request must be in writing, and it must give a detailed explanation of why the information should be amended. We reserve the right to deny your request under certain circumstances.
CONSENT TO TREATMENT
I understand the following:

1.       All my visits regarding the medical marijuana treatment with Dr. Pedro Oliveros are not covered by and will not be filed with my insurance company per Florida Statues. I understand that no fees associated with care or obtaining medical cannabis can be applied to any insurance plan, according to Florida State law. All fees will be paid by me or my legal representative.

2.       I understand that the cost of the initial visit to assess my candidacy for medical marijuana is $200. This includes medical evaluation, certification and order/recommendation (does not include Medical Marijuana Registration Card fee).

3.      I understand that Medical Marijuana may affect my blood pressure and heart rate. I agree to monitor my blood pressure regularly while undergoing trial of different strains of cannabis.

4.   I agree that the attending physician and his/her principals, agents, and employees, shall not be held responsibility for any harm resulting to me and/or other individuals as a result of my medicinal use of cannabis.

5.   I understand that I will not drive while taking high THC cannabis.

6.    I understand that the Federal Government’s classifies marijuana as a schedule I controlled substance. I understand that it is my responsibility to be informed regarding state and federal laws regarding the possession, use, sale/purchase and/or distribution of medical cannabis.

7.     (For patients currently taking opioids) I am aware that my current pain management physician may decide to discontinue prescribing my opioids if I am on medical cannabis. Dr. Oliveros is not obligated to take over my opioid management if that happens.

The undersigned hereby consents to the provision of examination/evaluation, treatment, therapies, medical and laboratory procedures, and drugs and supplies by the healthcare providers of Pedro T. Oliveros Jr., MD, and, acknowledges that no guarantee or assurance has been made to the results of such treatments, procedures or examinations.

I represent and affirm that I have read and understand the above and, that the information I have provider is true and correct. It is my understanding that Dr. Pedro Oliveros and his staff are relying on this. I have read the Consent for Treatment and other documents on the following pages and as the patient or patient’s authorized representative or general agent for the purpose of signing this form, I hereby accept its terms.
Signature*

Clear
MEDICAL MARIJUANA CONSENT FORM

A qualified physician may not delegate the responsibility of obtaining written informed consent to another person. The qualified patient, or the patient's parent or legal guardian if the patient is a minor, must initial each section of this consent form to indicate that the physician explained the information and, along with the qualified physician, must sign and date the informed consent form.

This consent form contains three parts. Part A must be completed by all patients. Part B is only required for patients under the age of 18 with a diagnosed terminal condition who receive a certification for medical marijuana in a smokable form. Part C is the signature block and must be completed by all patients.
Part A: Must be completed for ALL medical marijuana patients
a. The Federal Government's classification of marijuana as a Schedule I controlled substance.The federal government has classified marijuana as a Schedule I controlled substance. Schedule I substances are defined, in part, as having (I) a high potential for abuse; (2) no currently accepted medical use in treatment in the United States; and (3) a lack of accepted safety for use under medical supervision. Federal law prohibits the manufacture, distribution and possession of marijuana even in states, such as Florida, which have modified their state laws to treat marijuana as a medicine.When in the possession of medical marijuana, the patient or the patient's caregiver must have his or her medical marijuana use registry identification card in his or her possession at all times.*
Initials
b. The approval and oversight status of marijuana by the Food and Drug Administration.Marijuana has not been approved by the Food and Drug Administration for marketing as a drug. Therefore, the "manufacture" of marijuana for medical use is not subject to any federal standards, quality control, or other federal oversight. Marijuana may contain unknown quantities of active ingredients, which may vary in potency, impurities, contaminants, and substances in addition to THC, which is the primary psychoactive chemical component of marijuana.*
Initials
c. The potential for addiction.Some studies suggest that the use of marijuana by individuals may lead to a tolerance to, dependence on, or addiction to marijuana. I understand that if I require increasingly higher doses to achieve the same benefit or if I think that I may be developing a dependency on marijuana, I should contact Dr. Oliveros.*
Initials
d. The potential effect that marijuana may have on a patient's coordination, motor skills, and cognition, including a warning against operating heavy machinery, operating a motor vehicle, or engaging in activities that require a person to be alert or respond quickly.The use of marijuana can affect coordination, motor skills and cognition, i.e., the ability to think, judge and reason. Driving under the influence of cannabis can double the risk of vehicular accident, which escalates if alcohol is also influencing the driver. While using medical marijuana, I should not drive, operate heavy machinery or engage in any activities that require me to be alert and/or respond quickly and I should not participate in activities that may be dangerous to myself or others. I understand that if I drive while under the influence of marijuana, I can be arrested for "driving under the influence."*
Initials
e. The potential side effects of medical marijuana use.Potential side effects from the use of marijuana include, but are not limited to, the following: dizziness, anxiety, confusion, sedation, low blood pressure, impairment of short term memory, euphoria, difficulty in completing complex tasks, suppression of the body's immune system, may affect the production of sex hormones that lead to adverse effects, inability to concentrate, impaired motor skills, paranoia, psychotic symptoms, general apathy, depression and/or restlessness. Marijuana may exacerbate schizophrenia in persons predisposed to that disorder. In addition, the use of medical marijuana may cause me to talk or eat in excess, alter my perception of time and space and impair my judgment. Many medical authorities claim that use of medical marijuana, especially by persons younger than 25, can result in long‐term problems with attention, memory, learning, drug abuse, and schizophrenia.There is substantial evidence of a statistical association between long‐term cannabis smoking and worsening respiratory symptoms and more frequent chronic bronchitis episodes. Smoking marijuana is associated with large airway inflammation, increased airway resistance, and lung hyperinflation. Smoking cannabis, much like smoking tobacco, can introduce levels of volatile chemicals and tar in the lungs that may raise concerns about the risk of cancer and lung disease.I understand that using marijuana while consuming alcohol is not recommended. Additional side effects may become present when using both alcohol and marijuana.I agree to contact Dr. Oliveros if I experience any of the side effects listed above, or if I become depressed or psychotic, have suicidal thoughts, or experience crying spells. I will also contact Dr. Oliveros if I experience respiratory problems, changes in my normal sleeping patterns, extreme fatigue, increased irritability, or begin to withdraw from my family and/or friends.*
Initials
f. The risks, benefits, and drug interactions of marijuana.Signs of withdrawal can include: feelings of depression, sadness, irritability, insomnia, restlessness, agitation, loss of appetite, trouble concentrating, sleep disturbances and unusual tiredness.Symptoms of marijuana overdose include, but are not limited to, nausea, vomiting, hacking cough, disturbances in heart rhythms, numbness in the hands, feet, arms or legs, anxiety attacks and incapacitation. If I experience these symptoms, I agree to contact Dr. Oliveros immediately or go to the nearest emergency room.Numerous drugs are known to interact with marijuana and not all drug interactions are known. Some mixtures of medications can lead to serious and even fatal consequences.I agree to follow the directions of Dr. Oliveros regarding the use of prescription and non‐ prescription medication. I will advise any other of my treating physician(s) of my use of medical marijuana. Marijuana may increase the risk of bleeding, low blood pressure, elevated blood sugar, liver enzymes, and other bodily systems when taken with herbs and supplements. I agree to contact Dr. Oliveros immediately or go to the nearest emergency room if these symptoms occur.I understand that medical marijuana may have serious risks and may cause low birthweight or other abnormalities in babies. I will advise Dr. Oliveros if I become pregnant, try to get pregnant, or will be breastfeeding.*
Initial
g. The current state of research on the efficacy of marijuana to treat the qualifying conditions set forth in this section:
Cancer• There is insufficient evidence to support or refute the conclusion that cannabinoids are an effective treatment for cancers, including glioma.There is evidence to suggest that cannabinoids (and the endocannabinoid system more generally) may play a role in the cancer regulation processes. Due to a lack of recent, high quality reviews, a research gap exists concerning the effectiveness of cannabis or cannabinoids in treating cancer in general.• There is conclusive evidence that oral cannabinoids are effective antiemetics in the treatment of chemotherapy‐induced nausea and vomiting.There is insufficient evidence to support or refute the conclusion that cannabinoids are an effective treatment for cancer‐associated anorexia‐cachexia syndrome and anorexia nervosa.*
Initials
Epilepsy• There is insufficient evidence to support or refute the conclusion that cannabinoids are an effective treatment for epilepsy.Recent systematic reviews were unable to identify any randomized controlled trials evaluating the efficacy of cannabinoids for the treatment of epilepsy. Currently available clinical data therefore consist solely of uncontrolled case series, which do not provide high‐quality evidence of efficacy. Randomized trials of the efficacy of cannabidiol for different forms of epilepsy have been completed and await publication.*
Initials
Glaucoma• There is limited evidence that cannabinoids are an ineffective treatment for improving intraocular pressure associated with glaucoma.Lower intraocular pressure is a key target for glaucoma treatments. Nonrandomized studies in healthy volunteers and glaucoma patients have shown short‐term reductions in intraocular pressure with oral, topical eye drops, and intravenous cannabinoids, suggesting the potential for therapeutic benefit. A good‐quality systemic review identified a single small trial that found no effect of two cannabinoids, given as an oromucosal spray, on intraocular pressure. The quality of evidence for the finding of no effect is limited. However, to be effective, treatments targeting lower intraocular pressure must provide continual rather than transient reductions in intraocular pressure. To date, those studies showing positive effects have shown only short‐term benefit on intraocular pressure (hours), suggesting a limited potential for cannabinoids in the treatment of glaucoma.*
Initials
Positive status for human immunodeficiency virus• There is limited evidence that cannabis and oral cannabinoids are effective in increasing appetite and decreasing weight loss associated with HIV/AIDS.There does not appear to be good‐quality primary literature that reported on cannabis or cannabinoids as effective treatments for AIDS wasting syndrome.*
Initials
Acquired immune deficiency syndrome• There is limited evidence that cannabis and oral cannabinoids are effective in increasing appetite and decreasing weight loss associated with HIV/AIDS.There does not appear to be good‐quality primary literature that reported on cannabis or cannabinoids as effective treatments for AIDS wasting syndrome.*
Initials
Post‐traumatic stress disorder• There is limited evidence (a single, small fair‐quality trial) that nabilone is effective for improving symptoms of posttraumatic stress disorderA single, small crossover trial suggests potential benefit from the pharmaceutical cannabinoid nabilone. This limited evidence is most applicable to male veterans and contrasts with non‐ randomized studies showing limited evidence of a statistical association between cannabis use (plant derived forms) and increased severity of posttraumatic stress disorder symptoms among individuals with posttraumatic stress disorder. There are other trials that are in the process of being conducted and if successfully completed, they will add substantially to the knowledge base.*
Initials
Amyotrophic lateral sclerosis• There is insufficient evidence that cannabinoids are an effective treatment for symptoms associated with amyotrophic lateral sclerosis.Two small studies investigated the effect of dronabinol on symptoms associated with ALS. Although there were no differences from placebo in either trial, the sample sizes were small, the duration of the studies was short, and the dose of dronabinol may have been too small to ascertain any activity. The effect of cannabis was not investigated.*
Initials
Crohn's disease• There is insufficient evidence to support or refute the conclusion that dronabinol is an effective treatment for the symptoms of irritable bowel syndrome.Some studies suggest that marijuana in the form of cannabidiol may be beneficial in the treatment of inflammatory bowel diseases, including Crohn's disease.*
Initials
Parkinson's disease• There is insufficient evidence that cannabinoids are an effective treatment for the motor system symptoms associated with Parkinson's disease or the levodopainduced dyskinesia.Evidence suggests that the endocannabinoid system plays a meaningful role in certain neurodegenerative processes; thus, it may be useful to determine the efficacy of cannabinoids in treating the symptoms of neurodegenerative diseases. Small trials of oral cannabinoid preparations have demonstrated no benefit compared to a placebo in ameliorating the side effects of Parkinson's disease. A seven‐patient trial of nabilone suggested that it improved the dyskinesia associated with levodopa therapy, but the sample size limits the interpretation of the data. An observational study demonstrated improved outcomes, but the lack of a control group and the small sample size are limitations.*
Initials
Multiple sclerosis• There is substantial evidence that oral cannabinoids are an effective treatment for improving patient‐reported multiple sclerosis spasticity symptoms, but limited evidence for an effect on clinician‐measured spasticity.Based on evidence from randomized controlled trials included in systematic reviews, an oral cannabis extract, nabiximols, and orally administered THC are probably effective for reducing patient‐reported spasticity scores in patients with MS. The effect appears to be modest. These agents have not consistently demonstrated a benefit on clinician‐measured spasticity indices.*
Initials
Medical conditions of same kind or class as or comparable to the above qualifying medical conditions• The qualifying physician has provided the patient or the patient's parent or legal guardian a summary of the current research on the efficacy of marijuana to treat the patient's medical condition.• The summary is attached to this informed consent as Addendum*
Initials
Terminal conditions diagnosed by a physician other than the qualified physician issuing the physician certification• The qualifying physician has provided the patient or the patient's caregiver a summary of the current research on the efficacy of marijuana to treat the patient's terminal condition.• The summary is attached to this informed consent as Addendum*
Initials
Chronic nonmalignant pain• There is substantial evidence that cannabis is an effective treatment for chronic pain in adults.The majority of studies on pain evaluated nabiximols outside the United States. Only a handful of studies have evaluated the use of cannabis in the UnitedStates. and all of them evaluated cannabis in flower form provided by the National Institute on Drug Abuse. In contrast, many of the cannabis products that are sold in state‐regulated markets bear little resemblance to the products that are available for research at the federal level in the United States. Pain patients also use topical forms. While the use of cannabis for the treatment of pain is supported by well controlled clinical trials, very little is known about the efficacy, dose, routes of administration, or side effects of commonly used and commercially available cannabis products in the United States.*
Initials
h. That the patient's de‐identified health information contained in the physician certification and medical marijuana use registry may be used for research purposes.The Department of Health submits a data set to the Consortium for Medical Marijuana Clinical Outcomes Research for each patient registered in the medical marijuana use registry that includes the patient's qualifying medical condition and the daily dose amount and forms of marijuana certified for the patient.*
Initials
PART B: Certification for medical marijuana in a smokable marijuana for a patient under 18 with a diagnosed terminal condition.
Initial here if you are not a patient under 18 with a diagnosed terminal condition who will be receiving medical marijuana in a smokable form. After initialing here, complete part C.If the patient is under 18, has a diagnosed terminal condition, and will be receiving medical marijuana in a smokable form, please review and initial the remainder of Part B before completing Part C.
Initials
Respiratory Health Exposures to tobacco smoke and household air pollution consistently ranks among the top risk factors not only for respiratory disease burden but also for the global burden of disease. Given the known relations ships between tobacco smoking and multiple respiratory conditions, one could hypothesize that long‐term cannabis smoking leads to similar deleterious effects of respiratory health, and some investigators ague that cannabis smoking may be even more harmful that of tobacco smoking. Data collected from 15 volunteers suggest that smoking one cannabis joint can lead to four times the exposure to carbon monoxide and three to five times more tar deposition than smoking a single cigarette.Cognitive and Psychosocial DevelopmentResearchers are still studying the long‐term health effects of marijuana. Most people agree that marijuana use hurts adolescents more than adults. It is during the period of adolescence and young adulthood that the neural substrates that underlie the development of cognition are most active. Adolescence marks one of the most impressive stretches of neural and behavioral change with substantial a protracted development in terms of both brain structure and function. As a result, cannabis and other substance use during this period may incur relatively greater interference in neural, social, and academic functioning compared to late developmental periods.• There is moderate evidence of a statistical association between acute cannabis use and impairment in the cognitive domains of learning, memory, and attention.• There is limited evidence of a statistical association between sustain abstinence form cannabis use and impairments in the cognitive domains of learning, memory, and attention.• There is limited evidence of a statistical association between cannabis use and impaired academic achievement and education outcomes.• There is limited evidence of a statistical association between cannabis use and increased rates of unemployment and/or low income.• There is limited evidence of a statistical association between cannabis use and impaired social functioning or engagement in developmentally appropriate social roles.AddictionMarijuana, like some other brain‐altering substances, can be addictive. Nearly one in 10 marijuana users will become addicted. Starting to use marijuana at a younger age can lead to a greater risk of developing a substance use disorder later in life. Adolescents who begin using marijuana before age 18 are four to seven times more likely than adults to develop a marijuana use disorder.
Part C: For certification of smoking marijuana as an appropriate route of administration for a qualified patient, other than a patient diagnosed with a terminal condition
Acknowledgement of contaminant risks.Smokable marijuana has infectious risks that are not present in processed products. Certain molds and mildews can contaminate marijuana plants during growing, processing, storage in dispensaries and in patient homes. These contaminates can pose health risks, particularly to those who are immunosuppressed due to their disease state and treatments. While the State of Florida requires third party testing you should still inspect your product.Respiratory Health.Exposures to tobacco smoke and household air pollution consistently ranks among the top risk factors not only for respiratory disease burden but also for the global burden of disease. Given the known relations ships between tobacco smoking and multiple respiratory conditions, one could hypothesize that long‐term marijuana smoking leads to similar deleterious effects of respiratory health, and some investigators ague that marijuana smoking may be even more harmful that of tobacco smoking.Information regarding health risks of 2nd and 3rd hand smoke to other household members. You should never smoke medical marijuana around other family members, especially children and any household guests. You should smoke outside to allow adequate ventilation and to mitigate the dangers of secondhand and third hand smoke to others. Marijuana should never be smoked inside vehicles or other small spaces that children will occupy even if the children arenot present at the time the product is consumed.Dangers of smoking marijuana in households where oxygen is in use.If you use oxygen or have others in your household who use oxygen you should not smoke marijuana or any other combustible material in the vicinity of where the oxygen is in use due to the risk of fire and explosion.Self‐dosing, if permitted.I have been given instructions or discussed guidance on self‐ dosing with my qualified physician if permitted to do so.*
Initials
Part D: Must be completed for all medical marijuana patients
I understand that I am able to discuss these matters with the physician and to ask questions regarding anything I may not understand or that I believe needed to be clarified.
Initials
Signature*

Clear
Should be Empty: